Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Non-Current Assets (2022 - 2025)

Praxis Precision Medicines (PRAX) has 4 years of Non-Current Assets data on record, last reported at $327.0 million in Q4 2025.

  • For Q4 2025, Non-Current Assets rose 315.3% year-over-year to $327.0 million; the TTM value through Dec 2025 reached $741.0 million, up 187.31%, while the annual FY2025 figure was $327.0 million, 315.3% up from the prior year.
  • Non-Current Assets reached $327.0 million in Q4 2025 per PRAX's latest filing, up from $122.5 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $327.0 million in Q4 2025 and bottomed at $3.1 million in Q4 2023.
  • Average Non-Current Assets over 4 years is $64.5 million, with a median of $21.8 million recorded in 2022.
  • Peak YoY movement for Non-Current Assets: fell 28.45% in 2023, then surged 2466.43% in 2024.
  • A 4-year view of Non-Current Assets shows it stood at $4.3 million in 2022, then fell by 28.45% to $3.1 million in 2023, then soared by 2466.43% to $78.7 million in 2024, then skyrocketed by 315.3% to $327.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Assets were $327.0 million in Q4 2025, $122.5 million in Q3 2025, and $146.3 million in Q2 2025.